Drug intelligence / Profile preview

Cicaben

Development stage
Unknown
Lead developer
Orsana
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Cicaben is a multi-ingredient topical dermoprotective powder developed by the Italian company Orsana Italia. It is formulated to provide a combination of soothing, protective, and healing (cicatrizing) effects on compromised skin tissues. The product contains mineral oxides such as zinc oxide and magnesium oxide, which form a moisture-absorbing physical barrier that protects the skin from external irritants. It also incorporates Arnica montana extract for its anti-inflammatory and antiseptic properties, and niacinamide to support skin barrier function and reduce inflammation. Additionally, Cicaben contains allantoin and a blend of amino acids (arginine, glycine, and proline) that promote cellular repair and re-epithelialization. It is primarily indicated for the hygiene and healing of the neonatal umbilical cord stump, the management of decubitus ulcers (bedsores), the treatment of exudative dermatitis, and the care of small superficial abrasions.

Brand names
Cicaben
Other names
Cicaben powderCicaben polvere
02

Targets

PARP1 (Poly (adp-ribose) polymerase 1)NF-κB

Beyond the preview

Go deeper on Cicaben.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cicaben.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call